8-K - Precision Optics Corporation, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Precision Optics Corporation, Inc. closed a $10 million public offering of 2,777,777 common shares at $3.60 per share, with net proceeds for working capital and general corporate purposes.

Key Takeaways

1Entered underwriting agreement with Lucid Capital Markets on March 27, 2026 for 2,777,777 common shares at $3.60 public price.

2Granted 45-day over-allotment option for up to 416,667 additional shares.

3Net proceeds expected at $10.7 million including full over-allotment exercise after discounts.

4Issued Representative’s Warrants for 159,722 shares at $4.21 exercise price, exercisable from March 30, 2026 to March 27, 2031.

5Offering closed March 30, 2026 pursuant to effective Form S-3 registration.

6Underwriting discount up to 6.5% of gross proceeds.

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. | Entry into a Material Definitive Agreement. | |---|---| Underwriting Agreement On March 27, 2026, Precision Optics Corporation, Inc. (the “Company”) entered

Material Agreement

$3.60$10.7M$90.0K$4.21

3.02

. The Company issued the Representative’s Warrants pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, avail

Securities Issuance

8.01

. | Other Events. | |---|---| On March 26, 2026, the Company issued a press release announcing the proposed Offering. Additionally, on March 27, 2026, the Compa

Other Event

9.01

. | Financial Statements and Exhibits. | |---|---| (d) Exhibits | Exhibit No. | | Description | |---|---|---| | 1.1 | | Underwriting Agreement, dated March 27,

Exhibits Only

Source Document

Transaction Details

Material Agreement

Agreement: Underwriting Agreement
Parties: Precision Optics Corporation, Inc., Lucid Capital Markets, LLC

•Issuance of 2,777,777 shares of common stock at $3.60 per share
•45-day over-allotment option for 416,667 shares
•Underwriting discount up to 6.5% of gross proceeds
•Reimbursement of Underwriter expenses up to $90,000
•Issuance of Representative’s Warrants for 159,722 shares at $4.21 exercise price, exercisable March 30, 2026 to March 27, 2031
•Net proceeds approximately $10.7 million including full over-allotment for working capital and general corporate purposes

Exhibits (5)

1.1

UNDERWRITING AGREEMENT

4.1

COMMON STOCK PURCHASE WARRANT

8-K

FORM 8-K

99.1

PRESS RELEASE

99.2

PRESS RELEASE